ARKOPHARMA BELUX
The computed 12-month bankruptcy probability of ARKOPHARMA BELUX is 0.3% (very low). The 2023 annual accounts show equity of €1.91M and a net result of €400k. Equity is growing by ~5.4% per year across the filed fiscal years. Its solvency ranks better than 56% of 596 sector peers (fiscal year 2023). The company has been active since 1943 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1.91M |
| Net result | €400k |
| Staff (FTE) | 21.8 |
| Better than sector | 56% |
Strong profile, led by stability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 35.3% | 29.2% | |
| Net result | €400k | €35k | |
| Equity | €1.91M | €458k | |
| Staff costs | €2.00M | €487k | |
| Employees (FTE) | 21.8 | 7.5 |
Show 15 other metrics
| Fiscal year | 2023 |
|---|---|
| Deposit | volledig |
| Revenue | €8.52M |
| EBITDA | €683k |
| Net profit | €400k |
| Cash flow | €515k |
| Staff costs | €2.00M |
| Income taxes | €73k |
| Dividends | - |
| Total assets | €5.41M |
| Equity | €1.91M |
| Debt | €3.42M |
| of which ≤ 1y | €3.36M |
| of which > 1y | €50k |
| Working capital | €1.07M |
| Employees (FTE) | 21.8 |
| 2023 | |
|---|---|
| Current ratio | 1.32 |
| Quick ratio | 0.54 |
| Working capital ratio | 19.7% |
| Solvency | 35.3% |
| Debt / equity | 1.79 |
| Long-term debt ratio | 0.03 |
| Interest coverage | 11.27 |
| Gross margin | 52.1% |
| Net margin | 4.7% |
| ROA | 7.4% |
| ROE | 20.9% |
| EBITDA margin | 8.0% |
| Days sales outstanding | 40d |
| Days payable outstanding | 224d |
| Inventory turnover | 1.55 |
| Days inventory (DSI) | 236d |
Full annual accounts (26 line items)
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €5.41M |
| Fixed assets | 21/28 | €978k |
| Tangible fixed assets | 22/27 | €978k |
| Financial fixed assets | 28 | €0 |
| Current assets | 29/58 | €4.43M |
| Stocks & contracts in progress | 3 | €2.63M |
| Amounts receivable within one year | 40/41 | €1.64M |
| Cash & bank | 54/58 | €87k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €5.41M |
| Equity | 10/15 | €1.91M |
| Contributions / capital | 10/11 | €125k |
| Reserves | 13 | €246k |
| Accumulated profits (losses) | 14 | €1.54M |
| Provisions & deferred taxes | 16 | €83k |
| Amounts payable | 17/49 | €3.42M |
| Amounts payable after one year | 17 | €50k |
| Amounts payable within one year | 42/48 | €3.36M |
| Trade debts payable within one year | 44 | €2.51M |
| Income statement | ||
| Turnover | 70 | €8.52M |
| Operating result | 9901 | €568k |
| Financial income | 75 | €146 |
| Financial charges | 65 | €100k |
| Result before taxes | 9903 | €468k |
| Income taxes | 67/77 | €73k |
| Net result for the period | 9904 | €400k |
| Result to be appropriated | 9905 | €414k |
-
HW Conseil SASAdminstrateurState Gazette act 20149329 (15-12-2020)Current15-12-2020 → present
-
Patrick VerbelenAdminstrateur déléguéState Gazette act 20149329 (15-12-2020)Current15-12-2020 → present
-
Yann MalaudAdminstrateurState Gazette act 20149329 (15-12-2020)Current28-05-2020 → present
2 events
- 15-12-2020 Appointed· Adminstrateur
- 28-05-2020 Appointed· Managing director
Historic, not recently confirmed (2)
-
Hugues WitvoetManaging directorState Gazette act 20068699 (18-06-2020)Not recently confirmedlast confirmed in an act from 2020
-
Yannick GardetteDirectorState Gazette act 15145669 (15-10-2015)Not recently confirmedlast confirmed in an act from 2015
2 events
- 15-10-2015 Resigned· Director
- 15-10-2015 Appointed· Director
Former directors (4)
-
Jacques ChevalletManaging directorState Gazette act 15145668 (15-10-2015)Former15-10-2015 → 18-06-2020
2 events
- 18-06-2020 Resigned· Director
- 15-10-2015 Appointed· Managing director
-
Eric MASSOUDirectorState Gazette act 18184408 (27-12-2018)Former27-12-2018 → 28-05-2020
2 events
- 28-05-2020 Resigned· Managing director
- 27-12-2018 Appointed· Director
-
Jean-Jacques ROBERTDirectorState Gazette act 18184408 (27-12-2018)Former- → 27-12-2018
-
Philippe RombíManaging directorState Gazette act 15145669 (15-10-2015)Former- → 15-10-2015
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Baudouin Theunissen Commissaire succeeded by Mazars Réviseurs d'Entreprises in 2019 |
- | 13-02-2017 → 10-09-2019 |
Show 2 earlier auditors
| Mazars Réviseurs d'Entreprises Commissaire |
- | 10-09-2019 → 10-09-2019 |
| Serge Octave Commissaire succeeded by Mazars Réviseurs d'Entreprises in 2019 |
- | 13-02-2017 → 10-09-2019 |
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 23-12-1943 |
| Status | Active |
| Postal code | 1300 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25112C0079/00Z000 | Wallonia | 6,174 m² | 1 · 2,564 m² | 9.2 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 21 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
06-03-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "ARKOPHARMA BELUX"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 Anonyme",
"old": "Soci\u00E9t\u00E9 Anonyme",
"changed": false
}
}08-12-2023 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Patrick Verbelen",
"firm_city": null,
"firm_name": null,
"office_city": "Wavre",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-12-08",
"filing_date": "2023-10-15",
"act_kind_objet": "PROJET DE FUSION DE LA SA ARKOPHARMA BELUX ET DE LA SPRL"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-11-20",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0401.962.852",
"name": "Arkopharma Belux SA",
"role": "acquiring",
"address": "avenue edison 13, 1300 Wavre",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0457.571.962",
"name": "Phytonature",
"role": "absorbed",
"address": "avenue edison 13, 1300 Wavre",
"is_foreign": false,
"legal_form": "SPRL",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:50",
"12:57",
"12:7"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Le patrimoine int\u00E9gral, tant actif que passif, de la soci\u00E9t\u00E9 absorb\u00E9e est transf\u00E9r\u00E9 \u00E0 la soci\u00E9t\u00E9 absorbante. Cela inclut tous les droits, obligations, biens immobiliers et mobiliers, ainsi que les engagements financiers.",
"equity_transferred_eur": null,
"accounting_effective_date": "2022-11-30"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "Arkopharma Belux",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Patrick Verbelen",
"org_rep_person_name": null
},
"summary_narrative": "Le projet de fusion par absorption entre la soci\u00E9t\u00E9 anonyme Arkopharma Belux SA et la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e Phytonature a \u00E9t\u00E9 adopt\u00E9 par les conseils d\u0027administration des deux soci\u00E9t\u00E9s le 15 octobre 2023. La soci\u00E9t\u00E9 absorbante d\u00E9tient d\u00E9j\u00E0 toutes les actions de la soci\u00E9t\u00E9 absorb\u00E9e, ce qui permet une fusion silencieuse conform\u00E9ment \u00E0 l\u0027article 12:7 du Code des Soci\u00E9t\u00E9s et Associations. Le projet a \u00E9t\u00E9 d\u00E9pos\u00E9 au greffe le 20 novembre 2023, avec effet juridique pr\u00E9vu au 1er d\u00E9cembre 2023.",
"co_filed_documents": [],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}15-12-2020 3 directors appointed
- Patrick Verbelen, Adminstrateur délégué
- Yann Malaud, Adminstrateur
- HW Conseil SAS, Adminstrateur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "Adminstrateur D\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Patrick Verbelen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Adminstrateur",
"person": {
"rrn": null,
"name": "Yann Malaud",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Adminstrateur",
"person": {
"rrn": null,
"name": "HW Conseil SAS",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "Arkopharma Belux"
}
}18-06-2020 1 director appointed, 1 resigning
- Hugues Witvoet, Gedelegeerd bestuurder
- Jacques Chevallet, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jacques Chevallet",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Hugues Witvoet",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "Arkopharma Belux"
}
}28-05-2020 1 director appointed, 1 resigning
- Yann Malaud, Gedelegeerd bestuurder
- Eric Massou, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Eric Massou",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Yann Malaud",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "Arkopharma Belux"
}
}10-09-2019 Mazars Réviseurs d'Entreprises appointed as commissaire
- Mazars Réviseurs d'Entreprises, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Mazars R\u00E9viseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "Arkopharma Belux"
}
}27-12-2018 1 director appointed, 1 resigning
- Eric MASSOU, Bestuurder
- Jean-Jacques ROBERT, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jean-Jacques ROBERT",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Eric MASSOU",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "ARKOPHARMA Belux"
}
}20-09-2017 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "ARKOPHARMA Belux"
}
}13-02-2017 2 directors appointed
- Baudouin Theunissen, Commissaire
- Serge Octave, Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Baudouin Theunissen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Serge Octave",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "ARKOPHARMA BELUX"
}
}15-10-2015 1 director appointed, 1 resigning
- Jacques Chevallet, Gedelegeerd bestuurder
- Yannick Gardette, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Yannick Gardette",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Jacques Chevallet",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "ARKOPHARMA BELUX"
}
}15-10-2015 1 director appointed, 1 resigning
- Yannick Gardette, Bestuurder
- Philippe Rombí, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Philippe Romb\u00ED",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Yannick Gardette",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "ARKOPHARMA BELUX"
}
}09-07-2007 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "R\u00E1seiv",
"firm_city": null,
"firm_name": null,
"office_city": "Nivelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2007-07-09",
"filing_date": null,
"act_kind_objet": ""
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2007-06-28",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0401.962.852",
"name": "ARKOPHARMA BELUX SA",
"role": "acquiring",
"address": "Avenue Edison 13, 1300 Wavre",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": null,
"name": "PLANTE SYSTEM SA",
"role": "absorbed",
"address": "Avenue Edison 13, 1300 Wavre",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Le patrimoine entier de PLANTE SYSTEM SA est transf\u00E9r\u00E9 \u00E0 ARKOPHARMA BELUX SA, qui absorbe la soci\u00E9t\u00E9 par fusion.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "ARKOPHARMA BELUX",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "R\u00E1seiv",
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "Un projet de fusion par absorption est d\u00E9pos\u00E9 au greffe du tribunal de commerce de Nivelles. ARKOPHARMA BELUX SA (SA, KBO 0401.962.852) pr\u00E9voit d\u0027absorber PLANTE SYSTEM SA par fusion, sans \u00E9mission de nouveaux titres. L\u0027acte est d\u00E9pos\u00E9 le 28 juin 2007 et doit \u00EAtre publi\u00E9 aux annexes du Moniteur belge.",
"co_filed_documents": [],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}17-09-2002 Registered office moved from Watermael-Boitsfort to Wavre
- avenue des Noisetiers 7, 1170 Watermael-Boitsfort → avenue Edison 13, Parc de la Noire Épine, Zoning Nord, 1300 Wavre
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "avenue Edison 13, Parc de la Noire \u00C9pine, Zoning Nord, 1300 Wavre",
"city": "Wavre",
"region": "waals_gewest",
"street": "avenue Edison",
"country": "BE",
"postcode": "1300",
"box_number": null,
"street_number": "13",
"locality_suffix": null
},
"old_address": {
"raw": "avenue des Noisetiers 7, 1170 Watermael-Boitsfort",
"city": "Watermael-Boitsfort",
"region": "brussels_hoofdstedelijk_gewest",
"street": "avenue des Noisetiers",
"country": "BE",
"postcode": "1170",
"box_number": null,
"street_number": "7",
"locality_suffix": null
},
"effective_date": "2002-07-24",
"evidence_quote": "Le Conseil d\u0027Administration d\u00E9cide, \u00E0 l\u0027unanimit\u00E9 de transf\u00E9rer le si\u00E8ge social de la soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante: AVENUE EDISON 13 PARC DE LA NOIRE EPINE ZONING NORD 1300 WAVRE.",
"region_changed": true,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "J-L Deregnaucourt",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2002-09-17",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2002-07-24",
"unanimous": true
},
"subject_company": {
"kbo": "0401.962.852",
"name_full": "ARKOPHARMA BELUX",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "J-L Deregnaucourt",
"org_rep_person_name": null,
"person_role_at_subject": "administrateur-d\u00E9l\u00E9gu\u00E9"
},
"co_filed_documents": [
"Extrait du PV du Conseil d\u0027Administration du 24/07/2002"
]
}| Legal nameFR | ARKOPHARMA BELUX |